Your browser is no longer supported. Please, upgrade your browser.
MDCO The Medicines Company daily Stock Chart
MDCO [NASD]
The Medicines Company
Index- P/E- EPS (ttm)-3.13 Insider Own0.50% Shs Outstand79.75M Perf Week0.01%
Market Cap6.72B Forward P/E- EPS next Y-3.66 Insider Trans12.72% Shs Float77.12M Perf Month59.48%
Income-238.20M PEG- EPS next Q-0.84 Inst Own- Short Float29.89% Perf Quarter72.94%
Sales0.00M P/S- EPS this Y51.90% Inst Trans-0.20% Short Ratio6.35 Perf Half Y135.12%
Book/sh-0.32 P/B- EPS next Y-10.90% ROA-26.80% Target Price77.55 Perf Year326.21%
Cash/sh3.37 P/C25.02 EPS next 5Y37.00% ROE- 52W Range16.69 - 84.48 Perf YTD340.02%
Dividend- P/FCF- EPS past 5Y-60.50% ROI-18.20% 52W High-0.31% Beta1.09
Dividend %- Quick Ratio0.80 Sales past 5Y-60.30% Gross Margin- 52W Low404.61% ATR1.91
Employees62 Current Ratio0.80 Sales Q/Q- Oper. Margin- RSI (14)80.80 Volatility0.30% 2.56%
OptionableYes Debt/Eq- EPS Q/Q-31.50% Profit Margin- Rel Volume0.37 Prev Close84.03
ShortableYes LT Debt/Eq- EarningsJan 29 BMO Payout- Avg Volume3.63M Price84.22
Recom2.70 SMA209.86% SMA5033.50% SMA200100.11% Volume1,335,775 Change0.23%
Nov-25-19Downgrade Robert W. Baird Outperform → Neutral $85
Nov-25-19Downgrade Oppenheimer Outperform → Perform
Nov-20-19Downgrade Evercore ISI Outperform → In-line
Oct-10-19Downgrade Jefferies Buy → Hold $44 → $50
Sep-17-19Downgrade Citigroup Buy → Neutral $55
Jul-09-19Reiterated BofA/Merrill Buy $36 → $43
Apr-26-19Upgrade Goldman Neutral → Buy $25 → $55
Apr-26-19Reiterated Chardan Capital Markets Buy $85 → $90
Mar-28-19Initiated Robert W. Baird Outperform $80
Mar-21-19Initiated ROTH Capital Buy $75
Dec-14-18Initiated Wolfe Research Outperform
Dec-13-18Initiated Goldman Neutral $25
Jun-07-18Initiated B. Riley FBR, Inc. Buy $55
Jan-24-18Resumed JP Morgan Overweight $45
Oct-24-17Initiated Guggenheim Buy $45
Aug-29-17Reiterated Chardan Capital Markets Buy $80 → $85
Dec-05-16Initiated H.C. Wainwright Buy $57
Nov-16-16Reiterated RBC Capital Mkts Outperform $45 → $52
Nov-08-16Reiterated RBC Capital Mkts Outperform $48 → $45
Mar-21-16Reiterated Chardan Capital Markets Buy $50 → $65
Dec-15-19 07:06PM  Theres more upside for biotech even after 24% gains in two months MarketWatch
Dec-13-19 12:19PM  Biotech Stocks Burn A Hole In Big Pharma's Pocket; Look For More Mergers In 2020 Investor's Business Daily
Dec-11-19 08:32PM  Lifshitz & Miller LLP Announces Investigation of AK Steel Holding Corporation, Carbonite, Inc., Continental Building Products, Inc., KEMET Corporation, The Medicines Company, Tech Data Corporation, and Tiffany & Co. PR Newswire
Dec-10-19 09:30PM  BOLD, MDCO, AYR, and PEGI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts GlobeNewswire
06:30PM  SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of The Medicines Company - (NasdaqGS: MDCO) ACCESSWIRE
04:16PM  Why Biotech ETFs are Surging to New Highs Zacks
11:46AM  SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders MDCO, TIF, AMTD, CARO GlobeNewswire
Dec-09-19 01:30PM  MERGER ALERT - MDCO and TIF: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies ACCESSWIRE
Dec-07-19 02:04PM  30 momentum stocks that are actually cheap enough to buy MarketWatch
Dec-05-19 03:50PM  SHAREHOLDER ALERT: Monteverde & Associates PC Continues its Investigation on the Following Transaction ACCESSWIRE
03:44PM  Companies Are Merging Like Mad. That Might Signal a Looming Economic Slowdown. Barrons.com
Dec-04-19 10:45AM  MERGER ALERT - MDCO and TIF: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies ACCESSWIRE
08:00AM  INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders AMTD, TIF, MDCO, PGNX GlobeNewswire
Dec-03-19 11:00PM  MDCO, IPHS, BREW, and CARB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts GlobeNewswire
Dec-02-19 06:22PM  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of THE MEDICINES COMPANY - MDCO PR Newswire
04:32PM  Hedge Funds Hit The Bullseye With This Stock Pick Insider Monkey
02:00PM  MERGER ALERT - MDCO, GRSH, and TIF: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies ACCESSWIRE
07:00AM  Heart Drugs Are Having a Moment Bloomberg
Dec-01-19 09:30AM  The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More Benzinga
Nov-30-19 07:30AM  Notre Dame Is a Big Beneficiary of the Medicines Buyout Barrons.com
Nov-29-19 01:23PM  This Biotech With 488% Growth In 2019 Just Gained A Price-Target Boost Investor's Business Daily
09:34AM  Alnylam Gets Second Product Approval Amid Stiff Competition Zacks
Nov-28-19 08:07AM  Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? Zacks
Nov-27-19 11:00PM  Novartis cholesterol deal highlights mass-market opportunity Financial Times
10:35AM  SHAREHOLDER ALERT: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - TIF, AMTD, MDCO ACCESSWIRE
Nov-26-19 05:26PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates The Medicines Co. PR Newswire
11:04AM  Stock Market News for Nov 26, 2019 Zacks
08:06AM  The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug Benzinga
07:19AM  Novartis Securities Investment Ltd -- Moody's affirms Novartis' A1 rating; stable outlook Moody's
06:07AM  4 Big Drug Stocks Ripe for Takeover After NVS-MDCO Deal Zacks
Nov-25-19 05:50PM  Merger Investigation Alert: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - MDCO, AMTD, TIF ACCESSWIRE +22.25%
05:21PM  The Dow Is Hitting New Highs Again Because Investors Expect a Trade DealSoon Barrons.com
04:58PM  Novartis buys The Medicines Co in $9.7B deal Yahoo Finance Video
03:31PM  PreMarket Prep Recap: Merger Monday, Tesla Two-Step, Street Fades Netflix Downgrade Benzinga
02:48PM  Biotech ETFs Pop After Novartis Acquires Medicines Co. ETF Trends
02:21PM  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of The Medicines Company PR Newswire
01:33PM  THE MEDICINES COMPANY ALERT: Bragar Eagel & Squire, P.C. Investigates the Proposed Sale of MDCO and Encourages Investors to Contact the Firm PR Newswire
12:49PM  The Dow Is Rising Because China Might Finally Target the Theft of Intellectual Property Barrons.com
12:09PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of The Medicines Company to Novartis AG is Fair to Shareholders GlobeNewswire
12:03PM  Novartis Confirms Deal To Acquire Medicines Company For $9.7B Benzinga
11:45AM  THE MEDICINES COMPANY SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout ACCESSWIRE
11:26AM  Shareholder Investigation Alert: Halper Sadeh LLP Investigates Whether the Sale of These Companies is Fair to Shareholders MDCO, AMTD, TIF, BREW GlobeNewswire
11:14AM  Why The Novartis-Medicines Deal Is A Boon For These Biotech Stocks Investor's Business Daily
11:14AM  Novartis' Takeover Of Medicines Puts The Spotlight On These Biotechs Investor's Business Daily
11:11AM  A Day of Mergers: TIF, AMTD, MDCO & More Zacks
11:01AM  Biggest Merger Monday in Awhile: TIF, AMTD, MDCO & More Zacks
10:27AM  Novartiss Deal for Medicines Company Is Good News for 2 More Stocks Barrons.com
09:48AM  Novartis to Pay $9.7 Billion in Latest Bet on New Technology Bloomberg
09:43AM  Novartis (NVS) to Acquire The Medicines Company for $9.7B Zacks
09:42AM  The Medicines Company to be Acquired by Novartis for $9.7B Zacks
08:41AM  This Biotech Deal Is a $10 Billion Leap of Faith Bloomberg
08:41AM  (MDCO) Alert: Johnson Fistel Investigates Proposed Sale of The Medicines Company; Is $85 a Fair Price? PR Newswire
08:37AM  Novartis Is Buying The Medicines Company for $9.7 Billion Barrons.com
08:02AM  Dow Jones Futures Signal Stock Market Rally On China, 3 Big Takeover Deals; Tesla Cybertruck Reservations Hit 200,000 Investor's Business Daily
04:35AM  [video]Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drugmaker Medicines Co. TheStreet.com
02:06AM  Tiffany, Schwab, Novartis, 'Frozen 2,' Jerome Powell - 5 Things You Must Know TheStreet.com
Nov-24-19 10:25PM  Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker Reuters
06:12PM  Novartis to buy drug maker The Medicines Co. for $9.7 billion MarketWatch
04:00PM  Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion Reuters
03:49PM  UPDATE 3-Novartis takes on Sanofi, Amgen with $9.7 bln takeover of heart drug maker Reuters
03:21PM  Novartis to buy U.S. biotech The Medicines Co. for $9.7 bln Reuters
03:05PM  The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion Business Wire
12:10PM  Novartis to Swallow Up The Medicines Company for $9.7 Billion TheStreet.com
09:17AM  Novartis Nears Deal to Buy Medicines Co. for $85/Share: WSJ Bloomberg
03:22AM  Novartis agrees $9.7bn deal for US cholesterol drugmaker Financial Times
03:13AM  [video]Novartis Reportedly Close to Buying Medicines Co. TheStreet.com
Nov-23-19 03:03PM  UPDATE 1-Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 bln- WSJ Reuters
02:32PM  Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ Reuters
Nov-21-19 09:56AM  The Medicines Company Soars Amid Acquisition Whispers Investopedia
09:54AM  Alnylam's Givosiran Gets FDA Nod for Acute Hepatic Porphyria Zacks
08:48AM  Implied Volatility Surging for Medicines Company (MDCO) Stock Options Zacks
Nov-20-19 08:41AM  Medicines Company Up on Rumors of Potential Buyout by Novartis Zacks
07:25AM  The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data Benzinga
07:15AM  Healthcare ETF (RYH) Hits New 52-Week High Zacks
Nov-19-19 11:12AM  The Medicines Company Stock Is Soaring Because Novartis Might Want to Buy It Barrons.com +19.71%
11:02AM  A $5 Billion Cholesterol Bet May Be an Overreach Bloomberg
10:54AM  Medicines Co. Is Said to Attract Suitors Including Novartis Bloomberg
09:16AM  Why Vanguards chief economist says there is an elevated risk of a large drawdown in stocks MarketWatch
08:57AM  UPDATE 1-Novartis eyes Medicines Co to boost cardio franchise - report Reuters
08:02AM  Dow Jones Futures: Home Depot Dives, Leading 5 Big Premarket Movers Investor's Business Daily
07:56AM  The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout Benzinga
06:19AM  Medicines Co. shares jump 17% in premarket after report of potential Novartis offer MarketWatch
05:46AM  Novartis declines comment on reported interest in Medicines Co Reuters
04:38AM  [video]Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover TheStreet.com
02:20AM  Home Depot, Kohl's, Boeing, Salesforce, Medicines Co. - 5 Things You Must Know TheStreet.com
Nov-18-19 04:15PM  Biotech Stock Hits Record High On Gene-Silencing Cholesterol Drug Investor's Business Daily +12.83%
10:27AM  Medicines Company Posts Full Inclisiran Data From ASCVD Study Zacks
09:00AM  The Medicines Company Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing Business Wire
Nov-17-19 08:42AM  The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down Benzinga
Nov-16-19 10:45AM  The Medicines Company Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing Business Wire
Nov-15-19 12:29AM  Edited Transcript of MDCO earnings conference call or presentation 30-Oct-19 12:30pm GMT Thomson Reuters StreetEvents
Nov-11-19 05:00AM  A Paradigm Change in Cardiovascular Treatment MoneyShow
Nov-06-19 04:30PM  The Medicines Company to Present Inclisiran Data from ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies at American Heart Association Scientific Sessions 2019 Business Wire
06:38AM  Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? Zacks
Nov-01-19 10:34AM  Alnylam's (ALNY) Q3 Earnings and Revenues Beat Estimates Zacks
Oct-31-19 11:54AM  Medicines Company (MDCO) Incurs Wider-Than-Expected Q3 Loss Zacks
Oct-30-19 08:55AM  Medicines Co. (MDCO) Reports Q3 Loss, Lags Revenue Estimates Zacks
07:00AM  The Medicines Company Reports Third-Quarter 2019 Financial Results and Achievement of Major Milestones for Inclisiran Business Wire
Oct-28-19 02:06PM  Biopharma Stock Screaming Buy Before Earnings Schaeffer's Investment Research
Oct-24-19 04:30PM  The Medicines Company to Announce Third Quarter 2019 Financial Results on October 30 Business Wire
The Medicines Company, a biopharmaceutical company, focuses on developing therapeutics for the treatment of therosclerotic cardiovascular disease. The company is developing Inclisiran, an investigational RNA interference therapeutic that inhibits production of proprotein convertase subtilisin/kexin type 9, which controls LDL-cholesterol levels. It has collaboration agreement with Alnylam Pharmaceuticals, Inc. The Medicines Company was founded in 1996 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rodin Stephen MEVP and General CounselAug 02Option Exercise8.385,00041,90033,139Aug 06 05:54 PM
Rodin Stephen MEVP and General CounselAug 02Sale34.825,000174,10028,139Aug 06 05:54 PM
DENNER ALEXANDER JDirectorJun 28Buy33.0050,0001,650,0004,202,000Jun 28 08:19 PM
DENNER ALEXANDER JDirectorMay 30Buy34.8150,0001,740,5004,152,000May 31 07:31 AM
DENNER ALEXANDER JDirectorMay 29Buy34.8535,0001,219,7504,102,000May 31 07:31 AM
DENNER ALEXANDER JDirectorMay 22Buy33.13139,0004,605,0704,067,000May 22 05:56 PM
DENNER ALEXANDER JDirectorMay 21Buy33.95132,0004,481,4003,928,000May 22 05:56 PM
DENNER ALEXANDER JDirectorMay 20Buy34.50160,0005,520,0003,796,000May 22 05:56 PM
DENNER ALEXANDER JDirectorMar 06Buy24.91248,1006,180,1713,636,000Mar 08 01:13 PM
DENNER ALEXANDER JDirectorMar 05Buy26.07181,9004,742,1333,387,900Mar 05 05:14 PM
DENNER ALEXANDER JDirectorMar 04Buy25.45325,0008,271,2503,206,000Mar 05 05:14 PM
DENNER ALEXANDER JDirectorMar 01Buy25.15100,0002,515,0002,881,000Mar 05 05:14 PM
Timney MarkChief Executive OfficerDec 21Buy17.902,92652,37529,789Dec 27 01:45 PM
DENNER ALEXANDER JDirectorDec 20Buy17.8910,000178,9002,781,000Dec 21 07:30 AM
Cox Christopher TEVP & Chief Corp. Dev. OfficerDec 20Buy17.70113,5002,008,950334,955Dec 21 07:22 AM
DENNER ALEXANDER JDirectorDec 18Buy18.1810,000181,8002,771,000Dec 18 04:16 PM
Timney MarkChief Executive OfficerDec 17Buy18.6026,863499,65226,863Dec 18 04:36 PM
DENNER ALEXANDER JDirectorDec 17Buy17.9120,000358,2002,761,000Dec 18 04:16 PM